Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
346
-
Total 13F shares, excl. options
-
66.3M
-
Shares change
-
-3.97M
-
Total reported value, excl. options
-
$4.94B
-
Value change
-
-$714M
-
Put/Call ratio
-
1.33
-
Number of buys
-
182
-
Number of sells
-
-247
-
Price
-
$74.53
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2021
542 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2021.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 346 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.3M shares
of 106M outstanding shares and own 62.73% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (8.03M shares), VANGUARD GROUP INC (7.37M shares), JANUS HENDERSON GROUP PLC (6.17M shares), BlackRock Inc. (5.51M shares), FMR LLC (4.43M shares), SANDS CAPITAL MANAGEMENT, LLC (3.03M shares), Avoro Capital Advisors LLC (2.15M shares), STATE STREET CORP (2.03M shares), ARK Investment Management LLC (1.86M shares), and Bank of New York Mellon Corp (1.79M shares).
This table shows the top 346 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.